Honeywell International Inc vs InMode Ltd — how do they compare? Honeywell International Inc trades at $207 (market cap $65.96B), while InMode Ltd trades at $14.07 (market cap $806.05M). The key difference: Honeywell International Inc is far larger — about 81.8× InMode Ltd's market cap, and Honeywell International Inc pays a 1.35% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 90 Days and InMode Ltd for 29 Days on average.
| HON | INMD | |
|---|---|---|
Market Cap | $65.96B | $806.05M |
Volume | 2,009,898 | 511,446 |
Sector | Industrials | Health |
52-Week High | $248.79 | $16.62 |
52-Week Low | $188.14 | $12.76 |
Typical Hold Time | 90 Days | 29 Days |
Enterprise Value | $90.75B | $309.39M |
Dividend Yield | 1.35% | — |
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 2.95% on the day, with a bearish technical signal despite strong fundamentals including a low P/E of 8 and robust profitability margins. Recent quarterly earnings have consistently beaten expectations, and the company secured a significant $300 million refinery project with Dangote. Analyst consensus remains strongly bullish with a $259.25 price target, representing 25% upside potential from current levels.
The stock presents a compelling value opportunity given its discounted valuation metrics and consistent earnings outperformance, though investors face near-term technical headwinds and execution risks from the company's recent strategic transformation into a pure-play automation business following the spin-off of its aerospace and advanced materials divisions.
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →